Impact Biomedical (IBO) Change in Accrued Expenses (2022 - 2026)
Impact Biomedical (IBO) reported Change in Accrued Expenses of $53,000 for Q3 2026, down 23.2% from $69,000 a year earlier but up 39.5% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Change in Accrued Expenses (2022 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Impact Biomedical's Change in Accrued Expenses came in at -$35,000; for FY2025, it was -$2,000.
- By year, Change in Accrued Expenses came in at -$35,000 in FY2024, $167,000 in FY2023 (+193.0%) and $57,000 in FY2022.
- Five-year quarterly Change in Accrued Expenses spans a low of -$183,000 in Q1 2024 and a high of $224,000 in Q4 2023.
- Year over year, Change in Accrued Expenses gained in three of the last six quarters, with growth averaging 51.0%.
- The high point for year-over-year Change in Accrued Expenses in five years was Q3 2024 (growth of 583.3%); the low point was Q4 2024 (a decline of 58.5%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $38,000 (Q2 2026), $16,000 (Q1 2026) and -$142,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | 53,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 53,000.00 |
| Jun 30, 2026 | 38,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Dec 31, 2025 | -142,000.00 |
| Sep 30, 2025 | 69,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 93,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | -183,000.00 |
| Dec 31, 2023 | 224,000.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | -50,000.00 |
| Mar 31, 2023 | -13,000.00 |
| Dec 31, 2022 | 51,000.00 |
| Sep 30, 2022 | 7,000.00 |
API Access
Impact Biomedical Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();